Safety Alerts:
- Thyroid Tumors: Alert your healthcare provider immediately if you notice neck lumps, hoarseness, swallowing difficulty, or shortness of breath.
- Allergy Precautions: Do not use if allergic to semaglutide or other product components.
Usage Guidelines:
- Age and Condition Restrictions: Not for type 1 diabetes or individuals under 18.
- Medical History: Inform your doctor about any pancreatic, kidney, or vision issues related to diabetes, as well as pregnancy or breastfeeding status.
Administration:
- Take precisely as directed by your doctor.
- Consume on an empty stomach with water.
- Avoid altering the tablet form (no splitting, crushing, or chewing).
- Eat or take other oral medications 30 minutes after ingestion.
Common Side Effects:
- May include nausea, abdominal pain, diarrhea, reduced appetite, vomiting, and constipation.
Weight Loss Benefits:
- Not Just for Blood Sugar: Many patients experience significant weight loss while using RYBELSUS®.
- Average Weight Loss: Patients typically lose around 2.3 kg with 7 mg and 3.7 kg with 14 mg dosages.
- Feeling Fuller: RYBELSUS® can increase satiety after meals, aiding in weight reduction.
How it Works:
- RYBELSUS® is a GLP-1 receptor agonist, which helps regulate blood sugar, especially post-meal, by stimulating insulin secretion and slowing gastric emptying.
Take the Next Step:
- Consult with your healthcare provider to see if RYBELSUS® is right for you.
- Read the RYBELSUS® medication guide for comprehensive information.
Remember: This summary is for educational purposes and does not replace professional medical advice. Always consult your healthcare provider for personalized guidance.
Reviews
There are no reviews yet.